Stenocare A/S
STENO.CO · CPH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | 0.30 | -0.24 | 10.41 |
| FCF Yield | -28.69% | -28.85% | -14.36% | -13.29% |
| EV / EBITDA | -1.13 | -2.83 | -8.89 | -8.84 |
| Quality | ||||
| ROIC | -244.73% | -41.92% | -41.26% | -30.05% |
| Gross Margin | -827.64% | -170.84% | -142.77% | -893.87% |
| Cash Conversion Ratio | 0.21 | 0.57 | 0.92 | 1.05 |
| Growth | ||||
| Revenue 3-Year CAGR | -20.78% | 33.62% | 182.83% | -43.61% |
| Free Cash Flow Growth | 29.67% | 36.02% | 3.88% | 46.82% |
| Safety | ||||
| Net Debt / EBITDA | -0.10 | -0.01 | -0.52 | 0.81 |
| Interest Coverage | -21.55 | -5.54 | -12.77 | -65.87 |
| Efficiency | ||||
| Inventory Turnover | 64.79 | 223.35 | 14.97 | 851.15 |
| Cash Conversion Cycle | 267.66 | 328.96 | 322.57 | 398.04 |